These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Potent Anticancer Efficacy of First-In-Class Cu Chen L; Fan Y; Qiu J; Laurent R; Li J; Bignon J; Mignani S; Caminade AM; Shi X; Majoral JP Chemistry; 2020 May; 26(26):5903-5910. PubMed ID: 32142179 [TBL] [Abstract][Full Text] [Related]
7. Phosphorus dendrimers for nanomedicine. Caminade AM Chem Commun (Camb); 2017 Aug; 53(71):9830-9838. PubMed ID: 28745767 [TBL] [Abstract][Full Text] [Related]
8. First-in-Class Phosphorus Dendritic Framework, a Wide Surface Functional Group Palette Bringing Noteworthy Anti-Cancer and Anti-Tuberculosis Activities: What Lessons to Learn? Mignani S; Bignon J; Shi X; Majoral JP Molecules; 2021 Jun; 26(12):. PubMed ID: 34204564 [TBL] [Abstract][Full Text] [Related]
9. Phosphorus Dendrimers as Nanotools against Cancers. Caminade AM Molecules; 2020 Jul; 25(15):. PubMed ID: 32708025 [TBL] [Abstract][Full Text] [Related]
10. Recent advances in multifunctional dendrimer-based complexes for cancer treatment. Shcharbin D; Zhogla V; Abashkin V; Gao Y; Majoral JP; Mignani S; Shen M; Bryszewska M; Shi X Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1951. PubMed ID: 38456205 [TBL] [Abstract][Full Text] [Related]
11. First-in-Class Combination Therapy of a Copper(II) Metallo-Phosphorus Dendrimer with Cytotoxic Agents. Mignani S; El Brahmi N; Cresteil T; Majoral JP Oncology; 2018; 94(5):324-328. PubMed ID: 29533961 [TBL] [Abstract][Full Text] [Related]
12. Dendrimers for cancer immunotherapy: Avidity-based drug delivery vehicles for effective anti-tumor immune response. Rawding PA; Bu J; Wang J; Kim DW; Drelich AJ; Kim Y; Hong S Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Mar; 14(2):e1752. PubMed ID: 34414690 [TBL] [Abstract][Full Text] [Related]
13. From metallodrugs to metallodendrimers for nanotherapy in oncology: a concise overview. El Kazzouli S; El Brahmi N; Mignani S; Bousmina M; Zablocka M; Majoral JP Curr Med Chem; 2012; 19(29):4995-5010. PubMed ID: 22963626 [TBL] [Abstract][Full Text] [Related]
14. Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives. Cheng Y; Zhao L; Li Y; Xu T Chem Soc Rev; 2011 May; 40(5):2673-703. PubMed ID: 21286593 [TBL] [Abstract][Full Text] [Related]
15. HIV-antigens charged on phosphorus dendrimers as tools for tolerogenic dendritic cells-based immunotherapy. Vacas-Córdoba E; Bastida H; Pion M; Hameau A; Ionov M; Bryszewska M; Caminade AM; Majoral JP; Muñoz-Fernández MÁ Curr Med Chem; 2014; 21(16):1898-909. PubMed ID: 24304285 [TBL] [Abstract][Full Text] [Related]
17. Recent progress in dendrimer-based nanomedicine development. Kim Y; Park EJ; Na DH Arch Pharm Res; 2018 Jun; 41(6):571-582. PubMed ID: 29450862 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of nanoscale dendritic RGD clusters for potential applications in tissue engineering and drug delivery. Yang H; Kao WJ Int J Nanomedicine; 2007; 2(1):89-99. PubMed ID: 17722516 [TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-Mediated Multiple Modulation of Bone Microenvironment To Tackle Osteoarthritis. Zhan M; Sun H; Wang Z; Li G; Yang R; Mignani S; Majoral JP; Shen M; Shi X ACS Nano; 2024 Apr; 18(15):10625-10641. PubMed ID: 38563322 [TBL] [Abstract][Full Text] [Related]
20. Multifunctional Dendrimer-Entrapped Gold Nanoparticles Conjugated with Doxorubicin for pH-Responsive Drug Delivery and Targeted Computed Tomography Imaging. Zhu J; Wang G; Alves CS; Tomás H; Xiong Z; Shen M; Rodrigues J; Shi X Langmuir; 2018 Oct; 34(41):12428-12435. PubMed ID: 30251859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]